Skip to main content

Induction of Pituitary Tumours and Hyperprolactinemia in Female Rats by Estrogens. The Effect of Apomorphine, Reserpine and L-DOPA

  • Conference paper

Part of the book series: Archives of Toxicology ((TOXICOLOGY,volume 4))

Abstract

Prolonged estrogen treatment induced an enlargement of the anterior pituitary gland and finally resulted in irreversible pituitary tumours.

Using continuous estrogen delivery [subcutaneous (s.c.) cholesterol-estrogen implants], the effects of ethinyl estradiol and the likewise synthetic estrogens STS 153 and STS 456 have been studied with or without concomitant administration of a progestogen without anti-estrogenic activities (STS 557).

There was a dose-dependent prolactin cell-stimulating effect of all these estrogens. Ethinyl estradiol (EE2) had the most marked effect followed by STS 456 which coincides with the relative uterotrophic activity found in rats and mice. The elevated serum prolactin levels in rats with an EE2 implant for 6 months could be reduced slightly but not significantly by apomorphine and reserpine at a daily dose of 100 μg/animal and 5 μg/animal, respectively. Daily administration of 300 μg L-dopa led to a slight but insignificant increase of serum prolactin.

The high pituitary weight and serum prolactin levels induced by long-term EE2 treatment were partially reversible after implant withdrawal.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Beck, W., Wuttke, W.: Desensitization of the dopaminergic inhibition of pituitary luteinizing hormone release by prolactin in ovariectomized rats. J. Endocr. 74, 67–74 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Breuer, H., Köster, G.: Interaction between estrogens and neurotransmitters: Biochemical mechanisms. Adv. Biosci. 15, 287–300 (1974)

    Google Scholar 

  • Goodman, G., Lawson, D.M., Gala, R. R.: The effects of neurotransmitter receptor antagonists on ether-induced prolactin release in ovariectomized, estrogen-treated rats. Proc. Soc. Exp. Biol. Med. 153, 225–229 (1976)

    PubMed  CAS  Google Scholar 

  • Horowski, R., Gräf, K.-J.: Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat. Neuroendocrinology 22, 273–284 (1976)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag

About this paper

Cite this paper

Koch, M., Oettel, M., Lauterbach, H., Freund, H. (1980). Induction of Pituitary Tumours and Hyperprolactinemia in Female Rats by Estrogens. The Effect of Apomorphine, Reserpine and L-DOPA. In: Chambers, P.L., Klinger, W. (eds) Further Studies in the Assessment of Toxic Actions. Archives of Toxicology, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67729-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67729-8_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-10191-8

  • Online ISBN: 978-3-642-67729-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics